EDP

DEVICE2 trials

Sponsors

Zhujiang Hospital, Amgen

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseBioavailabilityBioequivalence

Phase 1

A Study of TEPEZZA Subcutaneous Administration in Healthy Adults

CompletedNCT06563856

AmgenBioavailability, Bioequivalence

Start: 2020-09-22End: 2021-05-27Updated: 2024-08-21

Unknown Phase

The Effect of EDP on Diaphragmatic Function and Neural Respiratory Drive in Patient With AECOPD

CompletedNCT03083418

Zhujiang HospitalAcute Exacerbation of Chronic Obstructive Pulmonary Disease

Start: 2016-10-31End: 2018-12-31Updated: 2024-03-13